HBA (n = 79) CBA (n = 79) P value
Clinical characteristics
Age (years) 64 ± 9 64 ± 10 0.98
Male sex 60 (76%) 62 (78%) 0.70
BMI (kg/m2) 25 ± 4 25 ± 4 0.93
AF duration (months) 6 ± 2 6 ± 3 0.61
AF lasting < 3 months 6 (8%) 12 (15%) 0.13
3-6 months 27 (34%) 28 (35%) 0.87
6-12 months 46 (58%) 39 (49%) 0.26
CHA2DS2-VASc score 2 (1, 3) 2 (1, 3) 1.00
Heart failure
12 (15%)
10 (13%)
0.65
Hypertension
39 (49%)
45 (57%)
0.34
Diabetes mellitus
11 (14%)
15 (19%)
0.39
Prior stroke
11 (14%)
8 (10%)
0.46
Vascular disease
6 (8%)
3 (4%)
0.49
Antiarrhythmic drug use 52 (66%) 54 (68%) 0.73
Class I 10 (13%) 14 (18%) 0.37
Class III or IV 12 (9%) 32 (38%) <0.001
β blocker 44 (56%) 29 (37%) 0.02
Anticoagulant drug use 79 (100%) 79 (100%) 1.00
Warfarin 2 (3%) 3 (4%) 1.00
DOAC 77 (97%) 76 (96%) 1.00
Echocardiographic variables
LVEF (%) 62 ± 13 62 ± 11 0.84
LAD (mm) 41 ± 6 41 ± 5 0.80